Telocapil
Telocapil Uses, Dosage, Side Effects, Food Interaction and all others data.
Telocapil is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus).
| Trade Name | Telocapil |
| Generic | Dihydromyricetin |
| Dihydromyricetin Other Names | (+)-ampelopsin, (+)-dihydromyricetin, Ampelopsin, Ampeloptin, Telocapil |
| Type | |
| Formula | C15H12O8 |
| Weight | Average: 320.251 Monoisotopic: 320.05321736 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Telocapil
